Surgical Oncologist Salary in 2026: Fellowship, Subspecialty Focus, and Academic vs. Community Pay

Surgical oncologists are general surgeons who have completed one to two years of subspecialty fellowship training in surgical oncology — typically through a Society of Surgical Oncology (SSO)-affiliated program — and specialize in the surgical management of solid tumors across multiple organ systems. Unlike organ-specific surgical subspecialists (hepatobiliary surgeons, colorectal surgeons), general surgical oncologists are trained to operate across a broad range of oncologic sites: breast cancer, melanoma and skin cancers, soft tissue sarcoma, gastrointestinal malignancies, retroperitoneal tumors, and endocrine cancers. In practice, most surgical oncologists at academic cancer centers develop an organ-system focus while maintaining broad training; community-based surgical oncologists may maintain broader scope to meet the needs of smaller cancer programs. Surgical oncology is among the higher-paid surgical subspecialties, reflecting the technical complexity of cancer resections, the multidisciplinary coordination requirements, and the emotional weight of working with patients facing life-threatening diagnoses.

Training and Credentialing

The pathway is five years of general surgery residency (ACGME-accredited) followed by one to two years of surgical oncology fellowship at an SSO-affiliated program. The SSO does not administer a separate board examination for surgical oncology; instead, surgical oncologists are board-certified by the American Board of Surgery in General Surgery. The SSO's fellowship match and program accreditation process ensures training quality. Most surgical oncologists complete two-year fellowships at high-volume National Cancer Institute (NCI)-designated cancer centers — Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Johns Hopkins, University of Chicago, University of Washington are among the most competitive fellowship programs. Hepatopancreatobiliary (HPB) surgical oncology is often trained separately through dedicated HPB fellowships (also one to two years); candidates who complete both a general surgical oncology fellowship and an HPB fellowship (sequentially or as part of a combined program) have the broadest operative scope in oncologic surgery. Breast surgical oncology can be pursued through general surgical oncology fellowship or through dedicated breast surgery fellowships, and is increasingly separating as a distinct subspecialty track.

Key CPT Codes and High-Value Surgical Oncology Procedures

• Pancreaticoduodenectomy/Whipple procedure (48153, 48150): One of the most technically complex abdominal operations; $2,000–$4,000 physician component; total operative time 4–8 hours; minimally invasive (robotic) Whipple is increasingly performed at high-volume HPB centers; requires high-volume center (>20 Whipple procedures/year) for acceptable outcomes; volume-outcome relationship is well-established for pancreatic surgery
• Hepatic resection (47100–47130): Partial hepatectomy for primary (HCC, cholangiocarcinoma) or metastatic (colorectal liver metastases) tumors; major hepatectomy (≥3 segments) generates $1,500–$3,000 physician component; laparoscopic/robotic hepatectomy is increasingly standard at high-volume HPB centers
• Cytoreductive surgery with HIPEC (49000 + 49905): Cytoreductive surgery (peritoneal debulking) with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal, gastric, appendiceal, and ovarian primaries; 8–12 hour operations; $3,000–$6,000 total physician component for complex cytoreduction with HIPEC; limited to specialized centers with HIPEC programs
• Esophagectomy (43107, 43112, 43117): Open or minimally invasive esophagectomy for esophageal cancer; Ivor Lewis, McKeown, transhiatal approaches; $1,800–$3,500 physician component; volume-outcome relationship is the strongest in surgery for esophagectomy — centers performing <10/year have significantly worse outcomes than high-volume centers performing >20/year
• Gastrectomy (43620, 43621): Total and subtotal gastrectomy for gastric cancer; D2 lymphadenectomy is standard for gastric cancer surgery; $1,200–$2,000 physician component; robotic gastrectomy with D2 dissection is increasingly adopted at Asian cancer centers and progressive Western programs
• Sentinel lymph node biopsy (38500 + 38900): Sentinel lymph node biopsy with intraoperative lymphatic mapping for breast cancer and melanoma; $400–$700 physician component; high-volume breast surgical oncologists performing 200+ SLNB annually generate significant procedure volume
• Retroperitoneal sarcoma resection (49215): Retroperitoneal soft tissue sarcoma resection often requires en bloc resection of adjacent organs (kidney, colon, psoas muscle); $1,500–$3,000 physician component; long-term outcomes improved at sarcoma reference centers performing >20 retroperitoneal sarcomas/year

Salary Ranges by Practice Setting and Subspecialty

• Academic NCI-designated cancer center (general surgical oncology): $380,000–$520,000; academic surgical oncologists at NCI-designated comprehensive cancer centers combine complex oncologic surgery with clinical trials, basic or translational research, and fellowship teaching; AAMC benchmark salaries for surgical oncology are above general surgery but below organ-specific procedural subspecialties; protected research time is available for NIH-funded surgical oncology researchers; PSLF-eligible at nonprofit academic cancer centers
• Academic HPB/pancreatic surgery focus: $450,000–$600,000; hepatobiliary surgical oncologists at high-volume academic programs (Whipple ≥50/year, hepatectomy ≥100/year) are among the highest-compensated academic surgeons; HPB volume-outcome requirements drive concentration at a small number of high-volume centers, giving HPB surgical oncologists strong negotiating leverage; minimally invasive HPB competency (robotic Whipple/hepatectomy) commands premium compensation at programs seeking to build or expand robotic platforms
• Comprehensive community cancer center (employed): $450,000–$620,000; community-based surgical oncologists at comprehensive cancer programs serve a broader population than academic centers and typically maintain broader operative scope; less research expectation allows higher clinical volume and RVU production; community cancer programs affiliated with academic networks (UAB, Duke, Mayo regional) may offer hybrid models with academic resources
• Private surgical oncology group or practice: $500,000–$700,000+; surgical oncologists who own or co-own a practice with ASC access generate the highest total compensation through professional fee plus facility fee revenue; private surgical oncology is less common than in general surgery but exists in larger cancer markets
• HIPEC program director: $500,000–$700,000+; cytoreductive surgery/HIPEC specialists are extremely rare (fewer than 200 surgeons nationwide with significant HIPEC volume) and command significant salary premium; hospitals building HIPEC programs actively recruit nationally and offer signing bonuses of $100,000–$200,000 for surgeons who can build and run the program

What we see at Ava Health

Surgical oncology recruitment is driven by two distinct segments: academic cancer center searches (slower, more relationship-driven, 6–12 month timelines) and community cancer center searches (faster, often urgent, 3–6 month timelines). The most acute community demand is for surgical oncologists who can build or rebuild a cancer surgery program — positions that require both technical excellence and the business development skills to build referral networks with medical oncologists, radiation oncologists, and primary care physicians. HPB-trained surgical oncologists have the shortest time-on-market in our pipeline: these candidates routinely receive 4–6 competitive offers during active search, and the programs that move most quickly (offer within 30 days of initial interview) are most successful in closing candidates. HIPEC program expansion is one of the highest-impact single searches we conduct — a new HIPEC program generates $2–4 million in downstream hospital revenue per year from peritoneal carcinomatosis cases that would otherwise travel to a competitor, making the surgical oncologist hire among the highest-ROI physician placements in oncology.

Related: General Surgeon Salary Guide, Hematologist-Oncologist Salary Guide, Breast Surgeon Salary Guide, Colorectal Surgeon Salary Guide.